American Journal of Epidemiology Vol. 140, No. 6: 518-525
Copyright © 1994 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Premenopausal Estradiol Levels and the Risk of Breast Cancer: A New Method of Controlling for Day of the Menstrual Cycle
1IPRO, Lake Success, NY
2Institute of Environmental Medicine, New York University Medical Center New York, NY
Reprint requests to Dr. Carl R. Rosenberg, IPRO, 1979 Marcus Avenue, First Hoer, Lake Success, NY 11042
Levels of total estradiol in premenopausal women vary widely over the course of the menstrual cycle with a spike at the time of ovulation and dissimilar patterns pre- and post-ovulation. Evaluating the association between breast cancer and premenopausal measurements of total estradiol when the measurements cannot be taken on a uniform day of the cycle is therefore a difficult methodological challenge. In a matched case-control study of breast cancer nested within a prospective study, premeno pausal serum samples obtained up to 7 years before breast cancer diagnosis were available for total estradiol assay. By fitting a three-piece spline model that regressed the logarithm of total estradlol (in estradlol) on day of menstrual cycle, the authors were able to adjust the measurements for day of the cycle on which they were collected by expressing them in terms of the number of standard deviations above or below the frtted In estradiol value for that day. Applying the adjusted measurements to the nested case-control study, they found evidence of a 1.5- to 2-fold risk for women in the upper two tertiles of in estradiol relative to women in the lowest tertile. Conditional logistic regression analysis for day-of-cycle-adjusted in estradiol treated as a continuous variable resulted in a relative risk estimate of 1.19 (95% confidence interval 0.91–1.55) per standard-deviation increase In adjusted In estradiol.
breast neoplasms; case-control studies; confounding factors (epidemiology); estradiol; menstruation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. H. Eliassen, R. G. Ziegler, B. Rosner, T. D. Veenstra, J. M. Roman, X. Xu, and S. E. Hankinson Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2- to 3-Year Period in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2860 - 2868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Arslan, R. E. Shore, Y. Afanasyeva, K. L. Koenig, P. Toniolo, and A. Zeleniuch-Jacquotte Circulating Estrogen Metabolites and Risk for Breast Cancer in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2273 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Howards, E. F. Schisterman, J. Wactawski-Wende, J. E. Reschke, A. A. Frazer, and K. M. Hovey Timing Clinic Visits to Phases of the Menstrual Cycle by Using a Fertility Monitor: The BioCycle Study Am. J. Epidemiol., January 1, 2009; 169(1): 105 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Tworoger, A. H. Eliassen, S. A. Missmer, H. Baer, J. Rich-Edwards, K. B. Michels, R. L. Barbieri, M. Dowsett, and S. E. Hankinson Birthweight and Body Size throughout Life in Relation to Sex Hormones and Prolactin Concentrations in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2494 - 2501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Michels, K. L. Terry, and W. C. Willett Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer Arch Intern Med, November 27, 2006; 166(21): 2395 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Eliassen, S. A. Missmer, S. S. Tworoger, D. Spiegelman, R. L. Barbieri, M. Dowsett, and S. E. Hankinson Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst, October 4, 2006; 98(19): 1406 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K Oka, A. Szuba, J. C Giacomini, and J. P Cooke A pilot study of l-arginine supplementation on functional capacity in peripheral arterial disease Vascular Medicine, November 1, 2005; 10(4): 265 - 274. [Abstract] [PDF]
|
|
|
|
|
|
R. Kaaks, F. Berrino, T. Key, S. Rinaldi, L. Dossus, C. Biessy, G. Secreto, P. Amiano, S. Bingham, H. Boeing, et al. Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst, May 18, 2005; 97(10): 755 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-S. Furberg, G. Jasienska, N. Bjurstam, P. A. Torjesen, A. Emaus, S. F. Lipson, P. T. Ellison, and I. Thune Metabolic and Hormonal Profiles: HDL Cholesterol as a Plausible Biomarker of Breast Cancer Risk. The Norwegian EBBA Study Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K Oka, A. Szuba, J. C Giacomini, and J. P Cooke Gender differences in perception of PAD: a pilot study Vascular Medicine, May 1, 2003; 8(2): 89 - 94. [Abstract] [PDF]
|
|
|
|
|
|
A. Arseven, J. M Guralnik, E. O'Brien, K. Liu, and M. M. McDermott Peripheral arterial disease and depressed mood in older men and women Vascular Medicine, November 1, 2001; 6(4): 229 - 234. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Liu, E. O'Brien, J. M. Guralnik, M. H. Criqui, G. J. Martin, P. Greenland, and M. McGrae McDermott Measuring Physical Activity in Peripheral Arterial Disease: A Comparison of Two Physical Activity Questionnaires with an Accelerometer Angiology, February 1, 2000; 51(2): 91 - 100. [Abstract] [PDF]
|
|